Enter your email below and start receiving one of the markets best alerts today!!!

Enter your email below and start receiving one of the markets best alerts today!!!

Monday, 20 February 2012

INTK +25% on Friday mornings alert! First resistance is higher yet !! (Friday's alert here)

INTK showed some impressive action the day of the alert (Friday Feb. 17) with 25% gains and 4.5 mil. in vol. it closed at .03 with a high of .033 The first resistance we could see is at .038 - .04 This is our breakout point on the weekly chart which is up 39.5%.

If you are trading INTK congrats on the 25% gains so far! The gains we are finding here at Charts by Originalnewt are definitely nothing to sneeze at and we are expecting more from this play in the short term!! Both the weekly and daily charts are showing some very impressive strength right now and we are looking forward to this coming week with INTK.


Weekly


Daily







ITKH .0023 - Chart is setting up nice since our last look at it (Here - original post)

ITKH sent out it's semi-annual report Feb. 14 and it looks very good, in our opinion! The company is impoving tremendously by reducing debt, making money and making more money year over year (link to S/A report -  http://www.otcmarkets.com/financialReportViewer?symbol=ITKH&id=72494 ) Take a few minutes to read through this and you will see the value in ITKH that others right now are missing.

We feel confident in calling bottom here and  that these consolidation/bottom prices won't last to much longer once the investing community gets their eyes and ears on this little gem called iTeknik Holding Corporation.

 ITKH is currently flying below the radar and as you can see in the weekly chart, building some nice strength to move upward on!


Weekly




Daily







Thursday, 16 February 2012

INTK .024

INTK is starting to show signs of a real nice reversal here! Look for vol. to increase into next week and continued bullish price action. We are betting big that INTK is gonna be another winner for us here in the near future!!

We will take a look at the weekly chart over the weekend.
Happy trading ;-)



Tuesday, 14 February 2012

BPAX!!! - Teva, BioSante Win FDA Approval to Sell Men’s Testosterone-Replacement Gel (news link here)

"BioSante, the original developer of Bio-T-Gel, estimates the market for male testosterone products is more than $1.2 billion in the U.S., where hypogonadism affects as many as 5 million men. BioSante, of Lincolnshire, Illinois, licensed the gel to Teva, the world’s largest generic-drug maker, and will receive milestone payments and royalties when the drug is commercialized."


The price of BPAX hit a low of 0.68 (our original price alert on Jan. 22 here http://chartsbyoriginalnewt.blogspot.com/2012/01/bpax-068-short-term-play-on-chart-and.html )Tues. bouncing off the lower trend line of the 2 month channel, as investors were waiting on FDA decision and closed the regular trading hours at 0.76, after hours trading saw an increase in price of 0.35 on 4.66 mil shares traded.



Monday, 6 February 2012

BPAX breakout! Possible 71% so far!! They just keep coming!!!

BPAX had an amazing day today on equally amazing volume. We have so far seen a possible 71% in gains since our original alert here http://chartsbyoriginalnewt.blogspot.com/2012/01/bpax-068-short-term-play-on-chart-and.html with a follow up here
But this is not all we expect from BPAX in the short term. The chart is showing some resistance in the $1.12 - $1.26 area but we feel the momentum is enough (after hours saw a close of $1.11) and with the strong base of which we are moving off BPAX could see $1.50 (fib. 50% retrace) within the week. We do remind everyone to trade smart and take profits along the way ;-)
Keep in mind that the FDA date is approaching, only 1 week away, Feb. 14.


"A subsidiary of Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) is the licensee for Bio-T-Gel™ (testosterone gel) for the treatment of male hypogonadism or low testosterone levels. Bio-T-Gel™ was developed initially by BioSante, and then it was licensed to Teva for late stage clinical development. Teva is responsible for all Bio-T-Gel™ regulatory and marketing activities.
An NDA for Bio-T-Gel™ is pending with the FDA and has a PDUFA date of February 14, 2012. BioSante received $1.5 million upfront on signing the license agreement and will receive royalties upon commercialization. The current U.S. market for male testosterone products is over $1.2 billion"


60min. chart is a beauty! and notice the rising vol. through the day!!